Laura Conforti
Nottingham, ENG NG72UH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Journal: Neurobiology of disease
Published: August 09, 2019
NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
Journal: Behavioural brain research
Published: October 04, 2017
NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
Journal: Current biology : CB
Published: December 21, 2016
Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues.
Journal: PloS one
Published: September 29, 2014
Wallerian degeneration: an emerging axon death pathway linking injury and disease.
Journal: Nature reviews. Neuroscience
Published: May 21, 2014
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration.
Journal: Cell death and differentiation
Published: April 11, 2014
Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease.
Journal: Neurobiology of aging
Published: November 28, 2013
Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues.
Journal: PloS one
Published: October 11, 2012
dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.
Journal: Science (New York, N.Y.)
Published: June 09, 2012
Diversification of NAD biological role: the importance of location.
Journal: The FEBS journal
Published: June 03, 2012
Last Updated: 09/26/2026